Tamivir is a brand name for the drug oseltamivir phosphate, which is the generic name for Tamiflu. Both Tamivir and Tamiflu contain the same active ingredient, oseltamivir, and are used to treat and prevent influenza (flu) [1].
What is Oseltamivir?
Oseltamivir is an antiviral medication that works by inhibiting the enzyme neuraminidase, which is essential for the release of new virus particles from infected cells. This action helps to limit the spread of the influenza virus within the body. It is typically prescribed for the treatment of uncomplicated influenza in individuals aged one year and older who have shown symptoms for no more than 48 hours. It can also be used for post-exposure prophylaxis, meaning to prevent the flu in individuals who have been exposed to the virus [2].
How Do Tamivir and Tamiflu Differ?
The primary difference between Tamivir and Tamiflu lies in their branding and manufacturer. Tamiflu is the original brand name under which oseltamivir was first marketed by its developer, Hoffmann-La Roche. Tamivir is a brand name used by a different pharmaceutical company, often for its generic version of oseltamivir phosphate. As generic medications, products like Tamivir are required to have the same active ingredient, dosage, strength, route of administration, safety, and intended use as the brand-name drug [1].
Can Generic Oseltamivir Be Used Interchangeably with Tamiflu?
Yes, generic oseltamivir products like Tamivir are considered therapeutically equivalent to Tamiflu. This means they are expected to have the same clinical effect and can be used interchangeably. Healthcare providers often prescribe or recommend generic alternatives to lower costs, as they are typically less expensive than brand-name medications [1].
When Does Tamiflu's Patent Expire?
The patent protection for Tamiflu has largely expired, allowing for the development and marketing of generic versions. Information on specific patent expiry dates and any remaining exclusivities can be found on resources like DrugPatentWatch.com [3]. The expiry of patents opens the door for increased competition and the availability of more affordable treatment options.